NCT05353413 is a NA clinical trial of Neuroimaging in Ischemic Optic Neuropathy, sponsored by Medical University of Bialystok.

Who is sponsoring NCT05353413?

NCT05353413 is sponsored by Medical University of Bialystok.

What drugs are being tested in NCT05353413?

Interventions in NCT05353413: Neuroimaging, VEP - visual evoked potential, Ophthalmology examination..

What condition does NCT05353413 study?

NCT05353413 studies Ischemic Optic Neuropathy, Optic Neuritis, Compressive Optic Neuropathy, Traumatic Optic Neuropathy, Toxic Optic Neuropathy, Hereditary Optic Neuropathies.

Is NCT05353413 still recruiting?

NCT05353413 is currently status unknown. Last updated 29 April 2022.

Last reviewed 2022-04-29 · How we verify

NCT05353413

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.

Status unknown NA Last updated 29 April 2022

What this trial tests

NA trial testing Neuroimaging in Ischemic Optic Neuropathy in 20 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
1 January 2024

1 January 2024

Quick facts

Lead sponsor	Medical University of Bialystok
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	diagnostic
Enrollment	20
Start date	1 January 2020
Primary completion	1 January 2024
Estimated completion	1 January 2024
Sites	1 location across Poland

Drugs / interventions tested

Neuroimaging
VEP - visual evoked potential
Ophthalmology examination.

Conditions studied

Ischemic Optic Neuropathy — all drugs for Ischemic Optic Neuropathy →
Optic Neuritis — all drugs for Optic Neuritis →
Compressive Optic Neuropathy — all drugs for Compressive Optic Neuropathy →
Traumatic Optic Neuropathy — all drugs for Traumatic Optic Neuropathy →

Sponsor

Medical University of Bialystok

Who can join

18 and older, any sex, with Ischemic Optic Neuropathy or Optic Neuritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the project is to create a new, non-invasive and safe protocol for the early diagnosis of various types of optic neuropathies with the use of diffusion magnetic resonance imaging

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Visualization of human optic nerve by diffusion tensor mapping and degree of neuropathy.
Łabieniec Ł, Lisowski Ł, Petrache HI, Hładuński M, et al · · 2022 · PMID 36508429 · DOI 10.1371/journal.pone.0278987

Verify or expand the search:

Other trials of Neuroimaging

Trials testing the same drug.

NCT07336992 — Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: · Phase 3 · not yet recruiting
NCT06874231 — Brain Connectivity Marker for Alzheimer's Disease · recruiting
NCT05698537 — Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda · completed
NCT05322343 — Biobank and Brain Health in Bordeaux. · recruiting
NCT04989608 — Correlation Between Cognition and Neuroimaging in TIA Patients · NA · recruiting

Other recruiting trials for Ischemic Optic Neuropathy

Currently open trials in the same condition.

NCT03475173 — New Non-invasive Modalities for Assessing Retinal Structure and Function · NA · recruiting

Other Medical University of Bialystok trials

Trials by the same sponsor.

NCT07496957 — Preserflo MicroShunt Versus Trabeculectomy · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07325552 — iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment · NA · recruiting
NCT07529145 — Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment · recruiting
NCT06855979 — The Impact of Dietary Intervention on Oxidative/antioxidant Markers and Gut Microbiota in Athletes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05353413 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Bialystok
Last refreshed: 29 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05353413.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing